LIUMJEV

EUIPO EUIPO 2018 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark LIUMJEV was filed as Word mark on 07/04/2018 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/09/2019. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 017926472
Application date July 4, 2018
Publication date September 28, 2018
Entry date January 9, 2019
Expiration date July 4, 2028

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations namely, pharmaceutical preparations for the treatment, diagnosis and/or prevention of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders; pharmaceutical preparations for the prevention, diagnosis and/or treatment of headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention, diagnosis and/or treatment of inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention, diagnosis and/or treatment of neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy and ulcerative colitis; pharmaceutical preparations; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

Trademark history

Date Document number Area Entry
April 5, 2019 Change Representative, Published
December 20, 2018 Change Representative, Registered

ID: 11017926472